Viatris Inc. Files Q1 2025 10-Q
Ticker: VTRS · Form: 10-Q · Filed: May 8, 2025 · CIK: 1792044
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Viatris Q1 2025 10-Q filed. Financials out.
AI Summary
Viatris Inc. filed its 10-Q for the period ending March 31, 2025. The filing covers the first quarter of 2025 and provides financial details for the company, which was formerly known as Upjohn Inc. and incorporated in Delaware. The company's principal executive offices are located in Canonsburg, PA.
Why It Matters
This filing provides investors with the latest financial performance and operational details for Viatris Inc. during the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-08 — Filing Date (The date the report was officially submitted to the SEC.)
- 2025 Q1 — Fiscal Quarter (Specifies the first quarter of the fiscal year 2025.)
Key Players & Entities
- Viatris Inc. (company) — Filer of the 10-Q
- Upjohn Inc. (company) — Former name of Viatris Inc.
- 20250331 (date) — End of reporting period
- 20250508 (date) — Filing date
- Canonsburg, PA (location) — Business address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed with the SEC on May 8, 2025.
What was Viatris Inc. formerly known as?
Viatris Inc. was formerly known as Upjohn Inc.
Where are Viatris Inc.'s principal executive offices located?
Viatris Inc.'s principal executive offices are located at 1000 Mylan Boulevard, Canonsburg, PA 15317.
What is Viatris Inc.'s Standard Industrial Classification code?
Viatris Inc.'s Standard Industrial Classification code is 2834, for Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Viatris Inc (VTRS).